What is the classification of regorafenib? Regorafenib is a kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma. Regorafenib is an orally-administered inhibitor of multiple kinases. https://indiangenericprice.com/regorafenib-stivarga-cost-philippines https://indiangenericprice.com/regorafenib-stivarga-cost-usa